Top-News

Uran-Rallye: Preise ziehen wieder an – Jetzt nicht den Einstieg verpassen!(Anzeige)

THC Therapeutics News

Aktie

WKN: ISIN: US87248Q1013 US-Symbol: THCT

0,0033 $

+0,00 $

0,00%

08.05.24 18:43:24

Handeln Depot/Watchlist

Aktienanzahl *

-

Marktkapitalisierung *

-

Streubesitz

-

Index-Zugehörigkeit

-

IR-Website

THC Therapeutics News

29.12.21 - ACCESSWIRE

Kevin Bell CO-Founder & CEO of Kali Partners/VP of Tyson 2.0 joins THC Therapeutics

THCT plans for growth with focus on potential acquisitions in the Cannabis and Psychedelics industries

10.09.21 - ACCESSWIRE

THC Therapeutics Has Entered Into Agreement for up to $50 Million in Funding With a Private Equity Firm for M&A in the Cannabis Industry

Groundbreaking Leap Forward in THCT's New Business Plan.

31.08.21 - ACCESSWIRE

THC Therapeutics Appoints New CFO

Jonathan Cross, a private equity fund manager with over 33 years of experience, joins THC Therapeutics

26.05.21 - ACCESSWIRE

THC Therapeutics Exploring Entry Into Silver Market as an Online Precious Metals Dealer

THCT Investigating Unique Strategy in Precious Metals Industry With a Special Interest in Silver Assets

27.04.21 - ACCESSWIRE

THC Therapeutics Hires Dr. Jesse Dean III, Former Chiropractor of the Memphis Grizzlies & Sports Agent

THCT has signed a contract with Dr. Dean to introduce and negotiate an agreement between THC Therapeutics and one or more well-known celebrities in the cannabis industry that ...

23.04.21 - ACCESSWIRE

THC Therapeutics Has Completed the dHydronator(R) Consumer Model Design

THCT has leveraged the extensive market research commissioned through Keyhole Research to redesign the dHydronator® for the consumer market. This new design is in the ...

Newssuche

Videos

09:05 Uhr

Technical Trading: DAX dienstags Long

DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »

Uran-Rallye

Preise ziehen wieder an – Jetzt nicht den Einstieg verpassen
weiterlesen»

Anzeige